Funding

Revnu raises €2.6m to grow in the US while building its team in Manchester

The AI sales startup plans to expand its existing US customer base while keeping Manchester as its home for team-building and international growth.

Scaling in America Editorial01 Oct 2026
United Kingdom→U.S.
Company: Revnu
Illustrative Manchester technology workspace with laptops and large windows overlooking red-brick buildings.
Illustrative Manchester technology workspace with laptops and large windows overlooking red-brick buildings.

Manchester-based Revnu has raised €2.6 million ($3 million) to build its team and accelerate growth in the UK and US, according to EU-Startups. The AI sales platform already has much of its customer base in San Francisco, but its founders have chosen to build the business from northern England rather than relocate permanently to Silicon Valley.

The round was led by NPIF II – PXN Equity Finance, managed by PXN Ventures as part of the Northern Powerhouse Investment Fund II. Revnu also received backing from Y Combinator. Alongside its UK and US growth plans, the funding will support expansion into further international markets.

US customers, Manchester base

The US push is an effort to expand an existing customer foothold, rather than enter an entirely new market. Founders George Jefferson and Art Freebrey temporarily moved to Silicon Valley to participate in Y Combinator and considered building Revnu in San Francisco after the programme. They instead returned to Manchester, citing access to emerging engineering and technology talent.

“Y Combinator opened our eyes to the Silicon Valley ecosystem in a very positive way, but San Francisco wasn't the place to build for us,” said Jefferson, Revnu’s chief executive. He added that the company’s first hire was moving from London to Manchester.

That choice separates Revnu’s principal hiring base from an important customer market. The company is seeking to deepen US sales while building its team in the UK. The report gives no details of a permanent US office, US hiring targets or a timetable for further expansion.

Automating the work of a growth team

Founded in 2026, Revnu targets businesses whose owners lack the time or budget to run sustained customer-acquisition campaigns. Its platform deploys AI agents across channels including LinkedIn, TikTok and Instagram to run campaigns, test advertising, generate leads and book meetings.

Business owners can set budgets, while the software learns their company’s tone and objectives over time and provides performance updates. Jefferson describes the approach as testing channels, scaling activity that works and dropping activity that does not, while keeping founders informed.

Revnu is also developing generative engine optimisation capabilities, intended to help businesses become more visible in responses generated by services such as Google AI and ChatGPT. That extends its product ambitions beyond outbound sales and social advertising into AI-mediated discovery.

A busy funding field

The raise comes amid investment in European AI sales and marketing software. EU-Startups reported 2026 rounds including €8.4 million for Stockholm-based Agaton, €3.8 million for Helsinki’s Realm and €2 million for Vilnius-based Outcraft AI. In adjacent areas, London-based Searchable raised €11.9 million for AI-led search and performance marketing, while geoSurge secured €10 million for technology focused on brands’ representation in generative AI systems.

Those rounds show that Revnu is not alone in attracting capital to automate customer acquisition. Its US strategy builds on customer relationships and accelerator experience already established in Silicon Valley. The new funding is intended to turn that foothold into broader growth without moving the company’s base away from Manchester.

RevnuManchesterUS expansionAI salesY CombinatorPXN VenturesNPIF II

Related Stories

Keep reading
All Things British butter expanding across the United States through Whole Foods
Something & Nothing premium sodas as the UK-founded brand accelerates its expansion across the United States
AstraZeneca and Summit Therapeutics investment illustration
Expansion

AstraZeneca drops $2B into an American biotech

AstraZeneca is investing $2 billion in Miami-based Summit Therapeutics, giving the British pharmaceutical group rights equivalent to roughly 12% of Summit's outstanding common stock while the two companies launch a new cancer-treatment collaboration.

United Kingdom→Miami, FL

29 Sep 2026